Boston Scientific (LIM:BSX) Tax Provision : $-377 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Boston Scientific Tax Provision?

Boston Scientific's tax provision for the three months ended in Dec. 2023 was $-1 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was $-377 Mil.

Boston Scientific Tax Provision Historical Data

The historical data trend for Boston Scientific's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Tax Provision Chart

Boston Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

4,013.00

-2.00

-36.00

-443.00

-393.00

Boston Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Provision	Get a 7-Day Free Trial															-131.00	-156.00	-105.00	-1.00	-115.00

Boston Scientific Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-377 Mil.

Boston Scientific (LIM:BSX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (LIM:BSX) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy BSX:Germany B1SX34:Brazil BSXC:Austria

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.